Verastem, Inc.

VSTM Nasdaq SEC CIK 1526119
Follow Verastem Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $24M +113.6% vs same quarter last year
Net income −$74.7M +24.2% vs same quarter last year
EPS, diluted −$0.74 +45.2% vs same quarter last year
Operating cash flow −$33.6M +7.2% vs same quarter last year
Revenue by quarter
$0
$2.1M
$11.2M
$17.5M
$18.7M
$40.1M
$24M
Q4 24 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$30.9M−$209.5M
FY24$10M−$130.6M
FY23-−$87.4M
FY22$2.6M−$73.8M
FY21$2.1M−$71.2M
FY20$88.5M−$67.7M
FY19$17.5M−$149.2M
FY18$26.7M−$72.4M
FY17-−$67.8M
FY16-−$36.4M
FY15-−$57.9M
FY14-−$53.4M
FY13-−$41.2M
FY12-−$32M
FY11-−$13.7M
MarginsShare of revenue
  • Operating margin
  • Net margin
−4000%−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−550.3%−677.6%
FY24−1149.6%−1306.4%
FY23--
FY22−2809.6%−2843.3%
FY21−2991.2%−3468.1%
FY20−55.8%−76.5%
FY19−758.1%−854.8%
FY18−354.8%−271.1%
FY17--
FY16--
FY15--
FY14--
FY13--
FY12--
FY11--
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$104.8M
FY23-
FY22-
FY21−$53.7M
FY20−$33.5M
FY19−$138.5M
FY18−$76M
FY17-
FY16−$29.5M
FY15−$45.8M
FY14−$39.3M
FY13−$26.4M
FY12−$22.9M
FY11−$10.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Verastem
  • Healthcare median
−4000%−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearVerastemHealthcare median
FY25−677.6%−30.6%
FY24−1306.4%−47%
FY23-−58%
FY22−2843.3%−80.4%
FY21−3468.1%−71.8%
FY20−76.5%−62.2%
FY19−854.8%−46.2%
FY18−271.1%−49.6%
FY17-−45.9%
FY16-−36%
FY15-−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%